Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tonato

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Reliability and validity of a quality of life questionnaire in cancer patientsE Ballatori, F Roila, C Basurto, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer GroupL Crino, M Tonato, S Darwish, et al.
Cancer|January 15, 1996
The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical ResearchV De Lisi, G Cocconi, F Angelini, et al.
American Journal of Clinical Oncology|February 1, 1996
Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer. Long-term resultsM Colozza, S Gori, A M Mosconi, et al.
Infection|November 1, 1986
Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazoleF Menichetti, A Del Favero, R Guerciolini, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 1999
Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancerG V Scagliotti, L Crinó, E Pozzi, et al.
Journal of Surgical Oncology|June 22, 2000
Biological prognostic factors for early stage completely resected non-small cell lung cancerL Cagini, M Monacelli, G Giustozzi, et al.
Tumori|August 16, 2001
Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patientsS Gori, A M Mosconi, A Tabilio, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2001
Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancerS Novello, L Galli, A Antonuzzo, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1989
Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical ResearchF Roila, M Tonato, C Basurto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Reliability and validity of a quality of life questionnaire in cancer patientsE Ballatori, F Roila, C Basurto, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer GroupL Crino, M Tonato, S Darwish, et al.
Cancer|January 15, 1996
The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical ResearchV De Lisi, G Cocconi, F Angelini, et al.
American Journal of Clinical Oncology|February 1, 1996
Induction chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in a combined modality approach for locally advanced and inflammatory breast cancer. Long-term resultsM Colozza, S Gori, A M Mosconi, et al.
Infection|November 1, 1986
Empiric antimicrobial therapy in febrile granulocytopenic patients. Randomized prospective comparison of amikacin plus piperacillin with or without parenteral trimethoprim/sulphamethoxazoleF Menichetti, A Del Favero, R Guerciolini, et al.
Lung Cancer (Amsterdam, Netherlands)|August 31, 1999
Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancerG V Scagliotti, L Crinó, E Pozzi, et al.
Journal of Surgical Oncology|June 22, 2000
Biological prognostic factors for early stage completely resected non-small cell lung cancerL Cagini, M Monacelli, G Giustozzi, et al.
Tumori|August 16, 2001
Results of a prospective study with high-dose etoposide, thiotepa and carboplatin and peripheral blood stem cell rescue for high-risk stage II-IIIA and selected stage IV breast cancer patientsS Gori, A M Mosconi, A Tabilio, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2001
Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancerS Novello, L Galli, A Antonuzzo, et al.
Pageof 12